NCT03606616View on ClinicalTrials.gov

Prospective Feasibility Study Applying the ACOSOG Z0011 Criteria to Chinese Patients

CompletedOBSERVATIONAL
Enrollment

142

Participants

Timeline

Start Date

November 1, 2014

Primary Completion Date

November 30, 2019

Study Completion Date

November 30, 2019

Conditions
Breast CancerSentinel Lymph NodeLocal Recurrence of Malignant Tumor of Breast
Interventions
PROCEDURE

no further ALND arm

Patients meeting the Z0011 inclusion criteria to receive no additional ALND

Trial Locations (1)

100044

Peking university people's hospital, Beijing

All Listed Sponsors
lead

Peking University People's Hospital

OTHER

NCT03606616 - Prospective Feasibility Study Applying the ACOSOG Z0011 Criteria to Chinese Patients | Biotech Hunter | Biotech Hunter